9AZK
Macrocyclic inhibitors targeting the prime site of the fibrinolytic serine protease plasmin
This is a non-PDB format compatible entry.
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
| Synchrotron site | Australian Synchrotron |
| Beamline | MX2 |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2022-04-06 |
| Detector | ADSC QUANTUM 315r |
| Wavelength(s) | 0.9537 |
| Spacegroup name | P 1 21 1 |
| Unit cell lengths | 74.851, 128.875, 79.081 |
| Unit cell angles | 90.00, 108.06, 90.00 |
Refinement procedure
| Resolution | 47.760 - 2.100 |
| R-factor | 0.2379 |
| Rwork | 0.237 |
| R-free | 0.25490 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 5ugd |
| RMSD bond length | 0.013 |
| RMSD bond angle | 1.650 |
| Data reduction software | XDS |
| Data scaling software | XDS |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.19.2_4158) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 47.760 | 2.210 |
| High resolution limit [Å] | 2.100 | 2.100 |
| Rmerge | 0.221 | 1.599 |
| Rmeas | 0.240 | 1.742 |
| Rpim | 0.093 | 0.682 |
| Number of reflections | 82977 | 8220 |
| <I/σ(I)> | 7.4 | 1.5 |
| Completeness [%] | 99.8 | 99.77 |
| Redundancy | 6.5 | |
| CC(1/2) | 0.990 | 0.429 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 8.5 | 293 | 0.1 M Tris-HCl, 0.2 M ammonium phosphate monobasic |






